2023 International Congress

August 27-31, 2023. Copenhagen, Denmark.

View by Title View Categories

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Development and quantified evaluation of a continuous smartphone app-based monitoring approach to individualize Parkinson’s disease management.

F. Thieken, S. Wattendorf, P. Korn, M. Kontz, O. Ataiy, P. Fischer, MO. Ashraf, V. Gross, D. Pedrosa, K. Sohrabi, L. Timmermann (Marburg, Germany)
Development and validation of a new wearable device for the differential diagnosis of resting tremor

M. de Maria, F. Aracri, C. Calomino, M. Crasà, J. Buonocore, B. Vescio, A. Quattrone (Catanzaro, Italy)
Development and Validation of an Algorithm to Automatically Assess Motor Symptoms of Parkinson’s Disease

S. Sekimoto, G. Oyama, Y. Nonomiya, T. Hayashi, M. Soshi, S. Chiba, N. Hattori (Bunkyo-ku, Japan)
Development of a health-related quality-of-life (HR-QoL) questionnaire for hereditary spastic paraplegia (HSP) patients and caregivers.

J. Malina, E-M. Hüßler, B. Schröder, N. Wiesenberg, T. Kühl, S. Klebe (Essen, Germany)
Development of a patient journey map for people living with Parkinson’s disease

A. Albanese, R. Case, A. Amit, S. Ben-Hamo (Milan, Italy)
Development of a Vibro-Tactile Stimulation wristband for targeted therapy of Focal Task Specific Dystonias

S. Arjun, A. Singh, H. Singh, R. Jain, I. Ahuja (Chandigarh, India)
Development of an Item Bank for Assessing Psychosis in Parkinson’s Disease: A Systematic Review

G. Mangone, M. Tosin, C. Goetz, G. Stebbins, T. Mestre (Chicago, USA)
Development of potent, orally bioavailable, and highly selective LRRK2 PROTAC® degrader molecules as potential disease modifying therapeutics for Parkinson’s disease

K. Kelly, J. Meredith, L. Kimmel, S. Sparks, A. Desantis, D. Bryce, R. Wilson, J. Corradi, S. Keenan, G. Cadelina, J. Pizzano, A. Cacace (New Haven, USA)
Development of therapeutic substances for the disassembly of α-synuclein aggregates as disease-modifying treatment of synucleinopathies

A. Willuweit, M. Sevenich, G. Tamgüney, J. Mohrlüder, D. Willbold (Düsseldorf, Germany)
Diabetes impact on nigrostriatal vulnerability in Parkinson’s Disease

A. Galli, A. Pilotto, C. Zatti, C. Tirloni, A. Lupini, B. Paghera, A. Padovani (Brescia, Italy)

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z